the cure rates were 100 per cent for patients with mild dysplasia , 95 per cent for those with moderate dysplasia , 96 per cent for those with severe dysplasia and 91 per cent for those with carcinoma in situ .
C0334048
severe dysplasia
C0007099
carcinoma in situ